Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Advances in the Development of Anti-FLT3 CAR T-Cell Therapies for Treatment of AML
Maya Graham Pedersen, Bjarne Kuno Møller, Rasmus O. Bak
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2441-2441
Open Access | Times Cited: 10

Showing 10 citing articles:

Targeting FLT3 Mutation in Acute Myeloid Leukemia: Current Strategies and Future Directions
Kateryna Fedorov, Abhishek Maiti, Marina Konopleva
Cancers (2023) Vol. 15, Iss. 8, pp. 2312-2312
Open Access | Times Cited: 23
Recent advances of CAR-T cells in acute myeloid leukemia
Huan Deng, Qi Wang, Xiaodong Tong, et al.
Therapeutic Advances in Hematology (2025) Vol. 16
Open Access | Times Cited: 1
Recent advances in CAR‐T cell therapy for acute myeloid leukaemia
C. Gao, Xin Li, Yao Xu, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 9
Open Access | Times Cited: 5
CAR-T Cells Immunotherapies for the Treatment of Acute Myeloid Leukemia—Recent Advances
Julia Zarychta, Adrian Kowalczyk, Milena Krawczyk, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2944-2944
Open Access | Times Cited: 10
CAR-T Therapy Beyond B-Cell Hematological Malignancies
Martina Canichella, Paolo de Fabritiis
Cells (2025) Vol. 14, Iss. 1, pp. 41-41
Open Access
Safety, tolerability, and pharmacokinetics of ASP1235 in relapsed or refractory acute myeloid leukemia: a phase 1 study
Monzr M. Al Malki, Mark D. Minden, Elizabeth Rich, et al.
Leukemia Research (2025), pp. 107690-107690
Closed Access
Broadening the horizon: potential applications of CAR-T cells beyond current indications
Hendrik Karsten, Ludwig Matrisch, Sophia Cichutek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Cell-Based Treatment in Acute Myeloid Leukemia Relapsed after Allogeneic Stem Cell Transplantation
Martina Canichella, Paolo de Fabritiis
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1721-1721
Open Access | Times Cited: 1
Challenges and Lessons Learned in Autologous Chimeric Antigen Receptor T-Cell Therapy Development from a Statistical Perspective
Daniel Li, Zhenzhen Xu, Shihua Wen, et al.
Therapeutic Innovation & Regulatory Science (2024) Vol. 58, Iss. 5, pp. 817-830
Closed Access
Recent Prospective in CAR T-Based Therapy for Solid and Hematological Malignancies
Hany E. Marei, Carlo Cenciarelli
Biomedicines (2023) Vol. 11, Iss. 2, pp. 627-627
Open Access
Page 1

Scroll to top